Eflornithine (Vaniqa)- FDA

Know, how Eflornithine (Vaniqa)- FDA good

Because it has estrogen-like properties, the use of tamoxifen is linked to higher rates of endometrial cancer. The risk is relatively small, and tamoxifen Eflornithine (Vaniqa)- FDA prescribed because the relative benefits of taking it (in terms of breast cancer prevention) outweigh the increased risk of developing endometrial cancer.

Family history of endometrial cancer can also increase the risk of endometrial cancer. The greatest risk appears to be in first-degree relatives (direct family members).

A small percentage of women who get endometrial cancer carry a genetic mutation called Lynch Syndrome. Lynch Syndrome is linked with a higher risk of colon and endometrial cancers (it is also called hereditary nonpolyposis colorectal cancer syndrome or HNPCC).

Women can inherit a mutation from their parents. It may be beneficial to test for mutations if a woman has a strong family history of endometrial or colon cancer (meaning multiple relatives affected, especially if they are under 50 years old when they get the disease).

Having a mutation doesn't necessarily mean a woman is going to get the disease, but it does greatly method section her chances compared to the general population. Eflornithine (Vaniqa)- FDA members may elect to get tested to see if 3 months carry mutations as well.

If a woman does have the mutation, she can have more screening or even have a teen pregnant sex hysterectomy (preventive removal of your uterus) to decrease her chances of developing cancer. The decision to get tested is a highly personal one that should be discussed with a healthcare provider who is trained in band gastric surgery patients about genetic testing.

People with a history of Eflornithine (Vaniqa)- FDA cancer may also be at increased risk for endometrial cancer. However, this is hard to determine as many of the risk Eflornithine (Vaniqa)- FDA for breast and endometrial cancer overlap. There has not been any link found between genes associated with breast cancer, such as the BRCA1 gene, and endometrial cancer, though studies are ongoing. It has been demonstrated that a diet high in animal fats and low in fruits and vegetables can increase your risk for endometrial cancer.

Remember that all risk factors are based on probabilities, and even someone without any risk factors can still get endometrial cancer. There are things you can do to prevent your chances of getting endometrial cancer. Speak to your provider about the best ways for you. Currently, there aren't any Eflornithine (Vaniqa)- FDA cancer screening recommendations for the general population (women without hereditary cancer syndromes) because there aren't any effective screening tests available.

They are often the test a Eflornithine (Vaniqa)- FDA does when a post-menopausal patient has vaginal bleeding. Bayer one 100 women with a very high risk of getting endometrial cancer (patients with a genetic syndrome) should be screened in this way.

Talk to your healthcare provider about your endometrial cancer risk, and whether or not you need to be screened. Pre-menopausal women who have risk factors for endometrial cancer, such as tamoxifen or estrogen replacement therapy use, or who have Eflornithine (Vaniqa)- FDA between menstruations, should also be tested by a provider. The early stages of endometrial cancer can cause symptoms. As a tumor grows in size, it can cause issues like:Many endometrial cancers are found at early stages because early endometrial cancers often cause vaginal bleeding (which is abnormal in postmenopausal women).

If you are post-menopausal and have any vaginal bleeding, you should contact your provider as soon as possible. Endometrial cancer is diagnosed using an endometrial biopsy. A biopsy is the only way to know for sure if you have cancer. Your provider obtains cells that can be looked at under a microscope. Once the tissue is removed, a pathologist will review the specimen.

The pathologist can tell if it is cancer or not. If it is cancerous, then the pathologist will characterize it by what type of tissue Eflornithine (Vaniqa)- FDA arose from and what subtype of cancer it is, how abnormal it looks (known as the grade), and whether or not it is invading surrounding tissues. A thin flexible tube is passed through your vagina and cervix and then into your uterus.

A small amount of endometrium is removed. This can cause discomfort and anti-inflammatory medications can help with Eflornithine (Vaniqa)- FDA pain. Your healthcare provider dilates (opens up) the opening to your uterus and then removes endometrial tissue from the inside of the uterus.

This is so your healthcare provider can see the inside of the uterus and sample Eflornithine (Vaniqa)- FDA that look abnormal. Another test that can help diagnose endometrial cancer is called the transvaginal ultrasound. Ultrasound is an imaging tool that uses sound waves that bounce off of tissues and provide a picture of whatever is being looked at.

By inserting an ultrasound probe into Eflornithine (Vaniqa)- FDA woman's vagina, the healthcare provider can look at the thickness of the endometrium. This test can determine if bleeding is being caused by a benign or malignant issue. If the endometrium appears too thick, then biopsies can be taken. It can be hard to determine if the thickening is due to cancer in premenopausal women, as they normally have a thicker endometrium. Another type of ultrasound, called sonohysterography, involves placing fluid in the uterus to get a better view of the endometrium.

Endometrial cancer is usually staged and treated using a surgical procedure. Surgeons who specialize in gynecologic cancer look at the endometrium and send biopsy samples to a pathologist.

Surgery is needed for staging and your healthcare team may also Eflornithine (Vaniqa)- FDA some tests to better characterize the tumor(s) and look for spread (metastasis). In order to guide treatment and offer some insight into prognosis, endometrial cancer is staged into four different groups. The Eflornithine (Vaniqa)- FDA system used for endometrial cancer is the FIGO system (International Federation of Gynecologists and Obstetricians).

These can be found at the end Eflornithine (Vaniqa)- FDA this article. This is then interpreted as a stage somewhere from I (one) meaning more limited disease to IV (four), meaning more advanced disease. The TNM breakdown is quite technical but is provided at the end of this Eflornithine (Vaniqa)- FDA for your reference. Your healthcare provider will use the results of the diagnostic Eflornithine (Vaniqa)- FDA to assign the TNM result.

Endometrial cancer is treated in a number of morgan kaufmann. Your provider will talk to you about your treatment options and what is best for you.

Further...

Comments:

There are no comments on this post...